Novocure Ltd Stock
Price
Target price
€11.19
€11.19
-0.840%
-0.095
-0.840%
-
02.01.26 / Tradegate
WKN: A140ML / Name: Novocure / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Novocure Ltd Stock
The price for the Novocure Ltd stock decreased slightly today. Compared to yesterday there is a change of -€0.095 (-0.840%).
Our community identified positive and negative aspects for Novocure Ltd stock for the coming years. 1 users see the criterium "Shareholder structure" as a plus for the Novocure Ltd stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Novocure Ltd in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novocure Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novocure Ltd | -0.840% | -0.666% | 19.015% | -61.735% | -1.323% | -83.764% | -91.924% |
| Ironwood Pharmaceuticals | - | -0.746% | -10.135% | -34.804% | - | -76.954% | -71.243% |
| Iovance Biotherapeutics Inc. | -9.250% | -10.413% | 16.874% | -71.704% | -9.507% | -64.243% | -94.474% |
| Alnylam Pharmace. | 0.560% | 0.946% | -12.845% | 49.956% | 0.738% | 53.187% | 220.409% |
News
Novocure: Steady Ahead of Key Milestones
Here's our initial take on Novocure's (NASDAQ: NVCR) fiscal 2025 second-quarter financial report.
Novocure reported no surprises in its latest quarter, with revenue up 6% for the year and both
